Related Experiment Videos

Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS

A J Berry1, M G Rinaldi, J R Graybill

  • 1Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas.

Insights

High-dose fluconazole shows potential as a salvage therapy for cryptococcal meningitis in patients with acquired immunodeficiency syndrome (AIDS). Despite previous treatment failures, this oral antifungal medication was well-tolerated, offering a new option for difficult-to-treat cases.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Pharmacology

Background:

  • Cryptococcal meningitis is a serious opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS).
  • Standard antifungal treatments may fail in some patients, necessitating alternative therapeutic strategies.
  • Salvage therapy options for refractory cryptococcal meningitis are limited.

Purpose of the Study:

  • To evaluate the efficacy and safety of high-dose oral fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
  • To assess the outcomes in patients who failed previous antifungal treatments.

Main Methods:

  • A cohort of eight patients with AIDS and cryptococcal meningitis was treated with oral fluconazole at 800 mg daily.
  • The mean duration of treatment was 4.5 months.
  • Patients included had previously failed other antifungal therapies.

Main Results:

  • All eight patients had a history of treatment failure with prior antifungal agents.
  • No major toxicity was observed during the fluconazole treatment.
  • Three patients (37.5%) died due to cryptococcal infection despite treatment.

Conclusions:

  • High-dose oral fluconazole may represent a viable salvage therapy option for cryptococcal meningitis in immunocompromised patients.
  • Further investigation is warranted to optimize its use in refractory cases.
  • Fluconazole demonstrated an acceptable safety profile in this patient group.

Related Concept Videos